Matthew Enriqguez, individually and on behalf of all others similarly situated V. Johnson & Johnson; Janssen Pharmaceuticals, Inc.; ACTA VIS Pharma, Inc.; and ACTA VIS LLC CAM-L-4677-18 Trial Oct. 10, 2019